atAdvocacy-logo-dark
  • Home
  • Influencers
  • Organizations
  • Newsletter
  • About Us
  • Contact Us

Urge Congress to end abusive, ineffective animal testing!

Target: United States Congress

It is absurd and irresponsible that in the 21st century we still force pharmaceutical companies to conduct extensive testing on animals for drug development — even when there are non-animal testing methods and when we know the animal tests are simply not predictive of the human response to drugs!

Animals and human bodies are obviously very different, which means animal testing data are not reliable in gauging the safety of drugs. Drugs found to be safe in nonclinical animal tests fail during human clinical trials at a shocking rate — but the law and FDA still requires these tests for product submission.

It’s long past time for the FDA to update its decades-old regulations.  We’ll help people and save animals in the process.

Add your name to urge Congress to immediately pass legislation to end abusive and ineffective animal testing! 

The FDA Modernization Act of 2021 would update the Federal Food, Drug and Cosmetics Act (FFDCA) of 1938 to allow the FDA to authorize the use of 21st-century science to determine the safety and efficacy of new drugs.

If enacted, it will lower drug costs, speed delivery of drugs to patients, reduce the number of animals used in science, and increase the safety and effectiveness of drugs and vaccines.

The FDA must update its regulations regarding new drugs, shed animal testing wherever possible, and substitute state-of-the-art, human-relevant nonclinical test methods. It’s just good science and common sense!

Add your name to call on Congress to pass the FDA Modernization Act of 2021 and bring drug testing rules into the 21st century!

take action

Sign now

By signing this petition, you may receive periodic updates from OD Action and its partners. You may unsubscribe at any time. For more information, please visit our privacy policy.

By signing this petition, you may receive periodic updates from OD Action and its partners. You may unsubscribe at any time. For more information, please visit our privacy policy.


© actl.ink All rights reserved | Terms and Conditions | Privacy Policy